With novel payload categories such as degraders ... these diverse mechanisms of action to develop the next blockbuster ADC. Across 3 days, you can gain critical insights to characterize the ...

This eBook explores the evolving ADC landscape, offering exclusive insights into clinical progress, regulatory approvals and ...

Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as Sutro continues to seek a partner – – Three INDs ...

AbbVie claims that Genmab turned a blind eye to trade secret theft allegedly used to support the development of ProfoundBio’s ...

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload ...

The presentations will underscore the versatility of Adcentrx's ADC platform, showing advancements in therapeutic window expansion, bystander effect optimization, and payload delivery improvements ...

These new data show how a novel anti-IL1RAP antibody can be combined with a cytotoxic payload to yield a highly potent and safe ADC.", said David Liberg, Chief Scientific Officer of Cantargia.

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, will present new ...

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target ...